Central obesity is associated with non-cirrhotic portal vein thrombosis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Hepatology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jhep.2015.08.024PMID 26334577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Portal Vein Thrombosis

  2020cited by this paper
• Reply to: "Procoagulant imbalance in patients with non-alcoholic fatty liver disease".

  2017cited by this paper
• Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis.

  2015cited by this paper
• Procoagulant imbalance in patients with non-alcoholic fatty liver disease.

  2014cited by this paper
• Procoagulant imbalance in patients with non-alcoholic fatty liver disease.

  2014cited by this paper
• Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.

  2014cited by this paper
• Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis

  2014cited by this paper
• Non-cirrhotic portal hypertension - diagnosis and management.

  2014cited by this paper
• Mechanisms linking leptin to arterial and venous thrombosis: potential pharmacological targets.

  2014cited by this paper
• Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  2014cited by this paper
• Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population

  2013cited by this paper
• Quantification of the visceral and subcutaneous fat by computed tomography: interobserver correlation of a single slice technique.

  2013cited by this paper
• Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients

  2012cited by this paper
• Increased coagulation factor VIII, IX, XI and XII activities in non‐alcoholic fatty liver disease

  2011cited by this paper
• Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study

  2010cited by this paper
• Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

  2010cited by this paper
• Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow‐up study

  2010cited by this paper
• Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.

  2010cited by this paper
• Anthropometric Measures of Obesity and Risk of Venous Thromboembolism: The Tromsø Study

  2010cited by this paper
• Impaired fibrinolysis as a risk factor for Budd-Chiari syndrome.

  2010cited by this paper
• Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology

  2009cited by this paper
• Anthropometry, Body Fat, and Venous Thromboembolism: A Danish Follow-Up Study

  2009cited by this paper
• Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Vascular disorders of the liver

  2009cited by this paper
• Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis

  2008cited by this paper
• Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis

  2007cited by this paper
• Portal vein thrombosis; risk factors, clinical presentation and treatment

  2007cited by this paper
• A review of the metabolic syndrome.

  2007cited by this paper
• Venous thromboembolism--a manifestation of the metabolic syndrome.

  2006cited by this paper
• Non‐alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non‐diabetic men. Role of visceral adipose tissue

  2005cited by this paper
• Metabolic syndrome: evaluation of pathological and therapeutic outcomes.

  2005cited by this paper
• Obesity as a risk factor in venous thromboembolism.

  2005cited by this paper
• Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use

  2003cited by this paper
• Spectrum of portal vein thrombosis in the West

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Extrahepatic portal vein thrombosis: aetiology and determinants of survival

  2001cited by this paper
• Plasminogen Activator Inhibitor Type-1 (Part One): Basic Mechanisms, Regulation, and Role for Thromboembolic Disease

  2001cited by this paper
• Mesenteric venous thrombosis.

  2001cited by this paper
• Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors

  2000cited by this paper
• Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity.

  1999cited by this paper
• A prospective study of risk factors for pulmonary embolism in women.

  1997cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Mesenteric venous thrombosis

  1982cited by this paper

• Portal Vein Thrombosis in Patients Without Cirrhosis: Current Practical Approaches and Treatment Strategies

  2025cites this paper
• Idiopathic Portal Vein Thrombosis Treated by Continuous Antithrombotic Therapy from a Catheter Placed in the Portal Vein via the Ligamentum Teres Hepatis—A Case Report—

  2025cites this paper
• EASL Clinical Practice Guidelines on vascular diseases of the liver.

  2025cites this paper
• Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.

  2024cites this paper
• Abdominal surgery in patients with chronic noncirrhotic extrahepatic portal vein obstruction: A multicenter retrospective study

  2024cites this paper
• Thrombotic complications following bariatric surgery: how medical tourism poses challenges to comprehensive care in obesity medicine

  2024cites this paper
• Prevalence and prognosis of patients with MASLD‐related cirrhosis after an ICU hospitalization in France: A single‐centre prospective study

  2024cites this paper
• Management of splanchnic vein thrombosis

  2023influential citation
• Conservatively Treated Mesenteric Vein Thrombosis in a 48-Year-Old Obese Female: A Case Report

  2023cites this paper
• Metabolic Disorders and Risk of Portal Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Thrombose porte aiguë et chronique

  2022cites this paper
• De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study

  2021cites this paper
• Idiopathic portal vein thrombosis not related to hepatic disease or malignancy

  2021cites this paper
• Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.

  2021cites this paper
• Percutaneous mechanical thrombectomy device assisted TIPS recanalization: a feasibility study

  2021cites this paper
• Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women.

  2021cites this paper
• Nomogram Model for Prediction of Portal Vein Thrombosis in Patients with Liver Cirrhosis After Splenectomy: A Retrospective Analysis of 2 Independent Cohorts

  2021cites this paper
• Applications of Fat Mapping

  2020cites this paper
• Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

  2020cites this paper
• Social and medical support initiatives in vascular liver diseases in France, from child to adult.

  2020cites this paper
• Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed.

  2020cites this paper
• Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

  2020cites this paper
• Central obesity in adult patients with optimal weight in primary health care

  2020cites this paper
• Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases

  2020cites this paper
• Portomesenteric thrombosis after robotic sleeve gastrectomy

  2020cites this paper
• Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis.

  2019cites this paper
• Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis

  2019cites this paper
• Risk factors and impact of portal vein thrombosis in liver transplantation.

  2019cites this paper
• Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy in patient with liver cirrhosis

  2019cites this paper
• Visceral fat is associated with cirrhotic portal vein thrombosis

  2019cites this paper
• Imaging and minimally invasive endovascular therapy in the management of portal vein thrombosis

  2018cites this paper
• Insulin Resistance and Portal Vein Thrombosis

  2018cites this paper
• Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

  2018cites this paper
• Obesity is not associated with an increased risk of portal vein thrombosis in cirrhotic patients

  2018cites this paper
• The epidemiology of Budd-Chiari syndrome in France.

  2018cites this paper
• Abdominal infection reveals a rare disease

  2018cites this paper
• Portomesenteric Vein Thrombosis Post-Laparoscopic Sleeve Gastrectomy: Case Series and Literature Review

  2017cites this paper
• Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

  2017cites this paper
• Recurrent Abdominal Pain after Laparoscopic Appendectomy.

  2017cites this paper
• A systematic review of portomesenteric vein thrombosis after sleeve gastrectomy.

  2017cites this paper
• Portal vein thrombosis: The role of imaging in the clinical setting.

  2017cites this paper
• A Comprehensive Approach to Hepatic Vascular Disease.

  2017cites this paper
• Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

  2017cites this paper
• Postprandial dysmetabolism: Too early or too late?

  2016cites this paper
• World Journal of Hepatology

  year unknowncites this paper